Russian Federation vs Saudi Arabia: Percentage of bloodstream infection due to Escherichia coli resistant
Russian Federation
58.5%
in 2021
Saudi Arabia
52.8%
in 2022
Russian Federation rank
13th
Saudi Arabia rank
16th
Percentage of bloodstream infection due to Escherichia coli resistant over time
- Russian Federation
- Saudi Arabia
How they compare
Russian Federation currently reports 58.5% against 52.8% in Saudi Arabia, a difference of 5.7%.
That makes Russian Federation's figure about 1.1 times Saudi Arabia's.
Across all 5 years both countries report, Russian Federation has been ahead every year.
Russian Federation ranks 13th and Saudi Arabia ranks 16th of 50 countries.
Russian Federation has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Russian Federation | Saudi Arabia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 66.0% | 54.3% | 11.7% | Russian Federation |
| 2020s | 65.8% | 55.6% | 10.2% | Russian Federation |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to escherichia coli resistant, Russian Federation or Saudi Arabia?
- Russian Federation, at 58.5% against 52.8% in Saudi Arabia as of 2021.
- What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Russian Federation and Saudi Arabia?
- 5.7%, with Russian Federation ahead.
- How many years of comparable data are there for Russian Federation and Saudi Arabia?
- 5 years are reported by both, from 2017 to 2021.
- How do Russian Federation and Saudi Arabia rank globally for percentage of bloodstream infection due to escherichia coli resistant?
- Russian Federation ranks 13th and Saudi Arabia ranks 16th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.